Literature DB >> 22232188

Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice.

Jennifer A Gaddy1, Brock A Arivett, Michael J McConnell, Rafael López-Rojas, Jerónimo Pachón, Luis A Actis.   

Abstract

Acinetobacter baumannii, which causes serious infections in immunocompromised patients, expresses high-affinity iron acquisition functions needed for growth under iron-limiting laboratory conditions. In this study, we determined that the initial interaction of the ATCC 19606(T) type strain with A549 human alveolar epithelial cells is independent of the production of BasD and BauA, proteins needed for acinetobactin biosynthesis and transport, respectively. In contrast, these proteins are required for this strain to persist within epithelial cells and cause their apoptotic death. Infection assays using Galleria mellonella larvae showed that impairment of acinetobactin biosynthesis and transport functions significantly reduces the ability of ATCC 19606(T) cells to persist and kill this host, a defect that was corrected by adding inorganic iron to the inocula. The results obtained with these ex vivo and in vivo approaches were validated using a mouse sepsis model, which showed that expression of the acinetobactin-mediated iron acquisition system is critical for ATCC 19606(T) to establish an infection and kill this vertebrate host. These observations demonstrate that the virulence of the ATCC 19606(T) strain depends on the expression of a fully active acinetobactin-mediated system. Interestingly, the three models also showed that impairment of BasD production results in an intermediate virulence phenotype compared to those of the parental strain and the BauA mutant. This observation suggests that acinetobactin intermediates or precursors play a virulence role, although their contribution to iron acquisition is less relevant than that of mature acinetobactin.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22232188      PMCID: PMC3294665          DOI: 10.1128/IAI.06279-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.

Authors:  J J De Voss; K Rutter; B G Schroeder; H Su; Y Zhu; C E Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 2.  Multidrug-resistant organisms in military wounds from Iraq and Afghanistan.

Authors:  Jason H Calhoun; Clinton K Murray; M M Manring
Journal:  Clin Orthop Relat Res       Date:  2008-03-18       Impact factor: 4.176

3.  Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity.

Authors:  Chul Hee Choi; Sung Hee Hyun; Ji Young Lee; Jun Sik Lee; Yong Seok Lee; Soon Ae Kim; Jeong-Pil Chae; Seung Min Yoo; Je Chul Lee
Journal:  Cell Microbiol       Date:  2007-08-30       Impact factor: 3.715

Review 4.  Iron metabolism and infection.

Authors:  Colin Ratledge
Journal:  Food Nutr Bull       Date:  2007-12       Impact factor: 2.069

Review 5.  Acinetobacter baumannii: emergence of a successful pathogen.

Authors:  Anton Y Peleg; Harald Seifert; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

Review 6.  An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii.

Authors:  Lenie Dijkshoorn; Alexandr Nemec; Harald Seifert
Journal:  Nat Rev Microbiol       Date:  2007-12       Impact factor: 60.633

7.  Rat pneumonia and soft-tissue infection models for the study of Acinetobacter baumannii biology.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Ulrike MacDonald; Nicole R Luke; Steven R Gill; Anthony A Campagnari
Journal:  Infect Immun       Date:  2008-06-09       Impact factor: 3.441

8.  Development of Galleria mellonella as an alternative infection model for the Burkholderia cepacia complex.

Authors:  Kimberley D Seed; Jonathan J Dennis
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

9.  Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.

Authors:  Mark A Schell; Lyla Lipscomb; David DeShazer
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

10.  Attributable mortality of Acinetobacter baumannii: no longer a controversial issue.

Authors:  Matthew E Falagas; Petros I Rafailidis
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  113 in total

1.  Host-microbe interactions that shape the pathogenesis of Acinetobacter baumannii infection.

Authors:  Brittany L Mortensen; Eric P Skaar
Journal:  Cell Microbiol       Date:  2012-06-14       Impact factor: 3.715

2.  Crystal Structure of the Siderophore Binding Protein BauB Bound to an Unusual 2:1 Complex Between Acinetobactin and Ferric Iron.

Authors:  Daniel C Bailey; Tabbetha J Bohac; Justin A Shapiro; Daryl E Giblin; Timothy A Wencewicz; Andrew M Gulick
Journal:  Biochemistry       Date:  2018-11-15       Impact factor: 3.162

Review 3.  Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options.

Authors:  Yohei Doi; Gerald L Murray; Anton Y Peleg
Journal:  Semin Respir Crit Care Med       Date:  2015-02-02       Impact factor: 3.119

4.  Role of the carboxy terminus of SecA in iron acquisition, protein translocation, and virulence of the bacterial pathogen Acinetobacter baumannii.

Authors:  Steven E Fiester; Chika C Nwugo; William F Penwell; John M Neary; Amber C Beckett; Brock A Arivett; Robert E Schmidt; Sarah C Geiger; Pamela L Connerly; Sharon M Menke; Andrew P Tomaras; Luis A Actis
Journal:  Infect Immun       Date:  2015-01-20       Impact factor: 3.441

Review 5.  Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.

Authors:  Darren Wong; Travis B Nielsen; Robert A Bonomo; Paul Pantapalangkoor; Brian Luna; Brad Spellberg
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  The effect of ISAba1-mediated adeN gene disruption on Acinetobacter baumannii pathogenesis.

Authors:  Man Hwan Oh; Chul Hee Choi; Je Chul Lee
Journal:  Virulence       Date:  2017-06-09       Impact factor: 5.882

7.  Non-nucleoside inhibitors of BasE, an adenylating enzyme in the siderophore biosynthetic pathway of the opportunistic pathogen Acinetobacter baumannii.

Authors:  João Neres; Curtis A Engelhart; Eric J Drake; Daniel J Wilson; Peng Fu; Helena I Boshoff; Clifton E Barry; Andrew M Gulick; Courtney C Aldrich
Journal:  J Med Chem       Date:  2013-03-13       Impact factor: 7.446

8.  Outer membrane Protein A plays a role in pathogenesis of Acinetobacter nosocomialis.

Authors:  Sang Woo Kim; Man Hwan Oh; So Hyun Jun; Hyejin Jeon; Seung Il Kim; Kwangho Kim; Yoo Chul Lee; Je Chul Lee
Journal:  Virulence       Date:  2016-01-13       Impact factor: 5.882

9.  Design, synthesis, and biological evaluation of α-hydroxyacyl-AMS inhibitors of amino acid adenylation enzymes.

Authors:  Tony D Davis; Poornima Mohandas; Maria I Chiriac; Glennon V Bythrow; Luis E N Quadri; Derek S Tan
Journal:  Bioorg Med Chem Lett       Date:  2016-09-16       Impact factor: 2.823

10.  Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains.

Authors:  Jessica A O'Hara; Lauretta A Ambe; Leila G Casella; Bethany M Townsend; Mark R Pelletier; Robert K Ernst; Robert M Q Shanks; Yohei Doi
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.